Neurocognitive Visual Reaction Training

Reaction Time Clinical Trial

Official title:

Neurocognitive Visual Reaction Training

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01972581
• Other study ID #: HBAPL-201309-191
• Status: Completed
• Phase: N/A
• First received: October 21, 2013
• Last updated: February 17, 2016
• Start date: October 2013
• Est. completion date: February 2016

Study information

• Verified date: February 2016
• Source: High Point University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Incorporating neurocognitive visual reaction training has been shown to increase bating performance in collegiate baseball players. However, poor methodology, such as lack of a control group and use of an unreliable outcome measure, limit the strength of the previous study. Therefore the purpose of this study is to determine the effects of neurocognitive visual reaction training on reaction time and coordination in an athletic population.

The purpose of this study is to determine the effects of neurocognitive visual reaction training on reaction time and coordination.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 21
• Est. completion date: February 2016
• Est. primary completion date: February 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• subjects that participate in a structured sport team

• between the ages of 18-65

• with or without a history of mild traumatic brain injury.

Exclusion Criteria:

• subjects currently under medical supervision and not fully cleared to participate in structured sport team.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)

Related Conditions & MeSH terms

• Reaction Time

Intervention

Other:
• Reaction Time Training

Locations

Country	Name	City	State
United States	Human Biomechanics and Physiology Laboratory	High Point	North Carolina

Sponsors (1)

Lead Sponsor	Collaborator
High Point University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of colored balls correctly identified		5 weeks	No
Secondary	Number of ball catches on alternate ball toss		5 weeks	No
Secondary	Reaction time on dynavision reaction board		5 Weeks	No